Startup Korsana Bio Reveals $175M Raised for a Better Brain-Penetrating Alzheimer’s Drug
Alzheimer’s disease can be treated with antibodies that clear away plaques of amyloid protein, but these medicines require frequent dosing and they introduce serious safety risks. Korsana Biosciences is developing a next-generation drug that could offer …